Related Experiment Video

Updated: Apr 3, 2026

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
13:00

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus

Published on: July 31, 2021

4.2K

Immunization of pregnant women: Future of early infant protection

Azure N Faucette1,2, Michael D Pawlitz1,2, Bo Pei1,2

  • 1a Department of Obstetrics and Gynecology ; Wayne State University ; Detroit , MI USA.

Human Vaccines & Immunotherapeutics
|September 15, 2015
PubMed

Insights

Maternal immunization offers protection for both mothers and infants against infectious diseases. Further research and public acceptance are crucial for expanding its benefits to more pregnant women and high-risk populations.

Area of Science:

  • Immunology
  • Vaccinology
  • Maternal-Fetal Medicine

Background:

  • Infants have limited antibody responses, increasing susceptibility to infections.
  • Vaccine-preventable diseases pose significant risks to pregnant women's health.
  • Maternal immunization can protect mothers and transfer immunity to infants.

Purpose of the Study:

  • To review the current state and future directions of maternal immunization.
  • To identify gaps in knowledge regarding vaccine efficacy and safety in pregnant women.
  • To address challenges in public acceptance and clinical trial inclusivity.

Main Methods:

  • Literature review of existing research on maternal vaccines.
  • Analysis of current recommendations and guidelines for maternal immunization.
  • Discussion of scientific advancements and clinical trial considerations.

Main Results:

  • Several vaccines are successfully recommended for pregnant women globally.
  • Gaps remain in understanding vaccine efficacy and safety for certain populations.
  • Public acceptance and inclusive clinical trials are key challenges.

Conclusions:

  • Maternal immunization is a vital strategy for protecting maternal and infant health.
  • Further research is needed to expand vaccine options and address safety concerns.
  • Integrating scientific advances and improving trial design are essential for broader success.

Keywords:
B cellantibodyclinical trialimmunizationinfectionmucosal immunityneonatal Fc receptorpregnancyvaccinevaccine safety

More Related Videos

Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic PolyI:C07:13

Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic PolyI:C

Published on: March 25, 2016

20.0K
Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring09:09

Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring

Published on: August 17, 2022

2.4K

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.5K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
37
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
129
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.2K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K